A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)

替扎尼定 医学 不良事件报告系统 不利影响 药理学 麻醉 内科学 痉挛
作者
Lorenzo Villa‐Zapata,Ainhoa Gómez-Lumbreras,John R. Horn,Malinda S. Tan,Richard D. Boyce,Daniel C. Malone
出处
期刊:Drug Safety [Adis, Springer Healthcare]
卷期号:45 (8): 863-871 被引量:9
标识
DOI:10.1007/s40264-022-01200-4
摘要

Tizanidine is primarily metabolized via cytochrome P450 (CYP) 1A2 and therefore medications that inhibit the enzyme will affect the clearance of tizanidine, leading to increased plasma concentrations of tizanidine and potentially serious adverse events.Our aim was to study the occurrence of adverse events reported in the FDA Adverse Event Reporting System (FAERS) involving the combination of tizanidine and drugs that inhibit the metabolic activity of CYP1A2.A disproportionality analysis of FAERS reports from 2004 quarter 1 through 2020 quarter 3 was conducted to calculate the reporting odds ratio (ROR) of reports mentioning tizanidine in a suspect or interacting role or having any role, a CYP1A2 inhibitor, and the following adverse events: hypotension, bradycardia, syncope, shock, cardiorespiratory arrest, and fall or fracture.A total of 89 reports were identified mentioning tizanidine, at least one CYP1A2 inhibitor, and one of the adverse events of interest. More than half of the reports identified tizanidine as having a suspect or interacting role (n = 59, 66.3%), and the reports more frequently involved women (n = 58, 65.1%). The median age was 56.1 years (standard deviation 17.1). Some of the important safety signals included interactions between tizanidine in a suspect or interacting role and ciprofloxacin (ROR for hypotension 28.1, 95% confidence interval [CI] 19.2-41.2) or fluvoxamine (ROR for hypotension 36.9, 95% CI 13.1-103.4), and also when reported in "any role" with ciprofloxacin (ROR for hypotension 6.3, 95% CI 4.7-8.5), fluvoxamine (ROR for hypotension 11.4, 95% CI 4.5-28.8), and zafirlukast (ROR for falls 16.0, 95% CI 6.1-42.1).Reports involving tizanidine and a CYP1A2 inhibitor have higher odds of reporting hypotension. This study suggests that concurrent use of tizanidine with CYP1A2 inhibitors may lead to serious health consequences associated with low blood pressure such as falls and fractures.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
研友_Z7Xvl8完成签到,获得积分10
1秒前
2秒前
LY发布了新的文献求助10
4秒前
10秒前
10秒前
小火车应助科研通管家采纳,获得10
10秒前
小火车应助科研通管家采纳,获得10
10秒前
10秒前
10秒前
10秒前
10秒前
ljq完成签到,获得积分0
10秒前
韦老虎发布了新的文献求助100
11秒前
暂时贫穷的研究生完成签到,获得积分10
17秒前
831143完成签到 ,获得积分0
17秒前
Star完成签到,获得积分10
19秒前
smile完成签到,获得积分10
20秒前
韦老虎发布了新的文献求助100
25秒前
Wen完成签到 ,获得积分10
31秒前
xiaofenzi完成签到,获得积分10
32秒前
Jimmy_King完成签到 ,获得积分10
34秒前
伶俐书蝶完成签到 ,获得积分10
36秒前
韦老虎发布了新的文献求助100
38秒前
Jeremy637完成签到 ,获得积分10
42秒前
史克珍香完成签到 ,获得积分10
43秒前
47秒前
XD824发布了新的文献求助10
51秒前
韦老虎发布了新的文献求助100
51秒前
白枫完成签到 ,获得积分10
53秒前
张静枝完成签到 ,获得积分10
56秒前
1分钟前
韦老虎发布了新的文献求助100
1分钟前
loey完成签到,获得积分10
1分钟前
1分钟前
Rabbit完成签到 ,获得积分10
1分钟前
aaaaa完成签到,获得积分10
1分钟前
锦慜完成签到 ,获得积分10
1分钟前
包容的忆灵完成签到 ,获得积分10
1分钟前
1分钟前
Fang完成签到,获得积分10
1分钟前
高分求助中
Introduction to Strong Mixing Conditions Volumes 1-3 500
Tip60 complex regulates eggshell formation and oviposition in the white-backed planthopper, providing effective targets for pest control 400
Optical and electric properties of monocrystalline synthetic diamond irradiated by neutrons 320
共融服務學習指南 300
Essentials of Pharmacoeconomics: Health Economics and Outcomes Research 3rd Edition. by Karen Rascati 300
Peking Blues // Liao San 300
Political Ideologies Their Origins and Impact 13 edition 240
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3800994
求助须知:如何正确求助?哪些是违规求助? 3346569
关于积分的说明 10329587
捐赠科研通 3063070
什么是DOI,文献DOI怎么找? 1681341
邀请新用户注册赠送积分活动 807491
科研通“疑难数据库(出版商)”最低求助积分说明 763726